ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain
about
Analysis of transcriptional modulation of the presenilin 1 gene promoter by ZNF237, a candidate binding partner of the Ets transcription factor ERMActivation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathwaysOncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastomaBRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinasesCentrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.Screen for multi-SUMO-binding proteins reveals a multi-SIM-binding mechanism for recruitment of the transcriptional regulator ZMYM2 to chromatin.The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.Targeting mutant fibroblast growth factor receptors in cancer.Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradationDiagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.Dimerization of cytosolic FGFR1 fusion proteins
P2860
Q24319602-91CA17C1-065F-42C8-BEEB-704FF7665E12Q24545984-C98577BB-5AA3-46B2-A647-5CF5F4DD9F7FQ24548250-6328A75B-BFEE-4285-BD76-E5B4081A5F53Q24599766-13E90EB0-F5F7-418B-A00D-CA383A2BC88CQ24685696-FCC305FA-FFA3-49A5-A4DF-254761DFF22FQ27824821-99D88661-512D-4D99-B809-DF66E89CD3C9Q28248761-51768A0D-C2E1-496C-80E9-0178D87DCDC0Q35127960-4B04B99B-0261-47C8-93A2-C1B4F682AE92Q35850692-908C9479-B143-4864-BD61-0C11FC20A480Q36055482-3F473FCB-9581-400A-8CC9-50DE1842C3E7Q37267228-F0BD5595-3AFB-4B38-B0B6-E9E495C2B2B1Q37849013-E3EE3109-F71F-4D7D-818B-C21DE9053818Q38316836-EB2BB151-04EA-480B-BADA-EFDC4EEECE3CQ39773538-165ABEA6-946E-452D-BCFD-52ACD424C7D8Q39818667-01DDA261-9395-4A7C-94C7-C3A2342F1BC7Q40974422-1E3AD4B6-C14F-49FB-8DE6-5D07431C3409Q50288666-0FDACD03-B2A2-4C96-B78E-EC7732082639
P2860
ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
name
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@ast
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@en
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@nl
type
label
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@ast
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@en
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@nl
prefLabel
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@ast
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@en
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@nl
P2093
P1433
P1476
ZNF198-FGFR1 transforming acti ...... ZNF198 oligomerization domain
@en
P2093
P304
P407
P577
2000-07-01T00:00:00Z